FDFT1 and mevalonic aciduria: This confirms the important role of the non-sterol isoprenoid GGPP in the hyper-inflammatory phenotype of MKD and makes supplementation of intermediate isoprenoids and/or inhibition of squalene synthase interesting options for potential treatment to prevent inflammatory episodes in MKD patients (34).